SCHEMBL3097499

SCHEMBL3097499

c1ccc2nc(CC3CCCCC3)ccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.54
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTR6 P50406 1/20 0.50
MMP1 P03956 1/20 0.46
MMP3 P08254 1/20 0.46
MMP9 P14780 1/20 0.46
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
CYSLTR2 Q9NS75 1/20 0.44
CYSLTR1 Q9Y271 1/20 0.44
ALOX5 P09917 3/20 0.43
KDM1A O60341 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16654345 0.98 FAAH (0.56) FAAHCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7504454 0.83 FAAH (0.52) FAAHCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL31019207 0.83 FAAH (0.52) FAAHCYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL16825153 0.82 FAAH (0.51) FAAHCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL20515340 0.78 FAAH (0.47) FAAHCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8965425 0.77 CYSLTR1 (0.64) CYSLTR2CYSLTR1ALOX5HDAC6
SCHEMBL1256827 0.76 CYP1A2 (0.75) FAAHCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL16654084 0.76 PDE10A (0.56) CYP1A2CYP2C9ALDH1A1KDM4ERAB9A
SCHEMBL30022074 0.76 KDM1A (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL19656391 0.76 KDM1A (0.56) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399673-B2 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-03-19 US disclosed
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators DRUNENTHAL GMBH (DE) 2012-10-04 US disclosed
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNJ2 FAAH 1779/4885CYP1A2 1298/4885CYP3A4 857/4885
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators KCNQ1, KCNQ2, KCNJ2 FAAH 1779/4885CYP1A2 1298/4885CYP3A4 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.